Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy, Safety, and Tolerability of LP352 in the Treatment of Seizures in Children and Adults with Dravet Syndrome

Project: Research

Project Details

StatusActive
Effective start/end date21/11/2520/11/27

Keywords

  • clinical trial
  • Dravet Syndrome
  • seizures

Clinical Trial Phase

  • Phase III (a & b)
  • External Sponsor